Walgreens is addressing the challenging retail sales environment by focusing on value. Earlier in June, the company rolled ...

The oil company denied it was in early talks to buy BP (BP), dismissing a [Wall Street Journal report]( ...

U.S. healthcare-segment sales were $2.1 billion, down $2.13 billion in the same period last year. The decline in sales was primarily driven by VillageMD sales decreasing 6.5%, the company said, ...

Pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) will be announcing earnings results this Thursday before market open.

Meanwhile, Walgreens' stock price is around $11.20 per share, which means there's around $0.25 per share in possible gains here for investors trying to arbitrage the takeover.

Shares of pharmacy chain Walgreens Boots Alliance (NASDAQ:WBA) jumped 7.4% in the morning session after the company agreed to be acquired by Sycamore Partners for $10 billion. The acquisition ...

Walgreens investors may be feeling jaded with these developments. Not only has the stock been an awful buy over the past five ...

Not only has the stock been an awful buy over the past five years (it has declined by more than 75% during that time frame), ... Walgreens investors may be feeling jaded with these developments.

For decades, investors have been able to rely on growing dividend payments from pharmacy retailer Walgreens Boots Alliance (WBA-0.57%).But earlier this year, the company announced that it would be ...

Walgreens Will Make Big Changes in 2025 Walgreens is on track to make significant changes in 2025, and one possibility is to sell itself. The news from late 2024 includes rumors of a debt-financed ...

Walgreens stock faces headwinds from retail challenges and macro pressures—JPMorgan ... According to InvestingPro analysis, the stock appears slightly undervalued based on its Fair Value metrics.